Samotolisib

SI-5332

Samotolisib, >98% (HPLC)

CAS No. : [1386874-06-1]

MDL No. : MFCD28411368

Synonyms : LY3023414

IUPAC Name : (S)-8-(5-(2-Hydroxypropan-2-yl)pyridin-3-yl)-1-(2-methoxypropyl)-3-methyl-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
250MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
500MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Samotolisib is a dual inhibitor of phosphoinositide 3-kinase (PI3K) mammalian target of rapamycin (mTOR). Samotolisib has been used in trials studying the treatment of neoplasm, solid tumor, colon cancer, brest cancer and advanced cancer, among others.

References : Smith C. M. et al.: Cancer Ther., 15(10), 2344-2356, 2016.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.